Results for "Understanding Pharmaceutical Distribution"
Member Spotlight: The Future of Cold Chain Solutions
For HDA service provider member AeroSafe Global, innovation and sustainability go hand in hand. Since 1995, the company has grown from a single laboratory in Rochester, New York, into a global leader on the cutting edge of cold chain technology solutions.
Discussing Solutions To Address Drug Shortages
HDA recently partnered with The Hill to facilitate an event, “Keeping Pharmacy Shelves Filled: Solutions to Address Drug Shortages,” which included speakers Rep. Larry Buschon, MD (R-Ind.); Heather Zenk, President of U.S. Supply Chain, Cencora; Dr. Mark McClellan, Director, Duke-Margolis Institute for Health Policy and Former FDA Commissioner; Michael Kleinrock, Lead Research Director, IQVIA Institute for Human Data Science; and Dr. Marta Wosińska, Senior Fellow, Center on Health Policy, The Brookings Institution. HDA President and CEO Chip Davis also sat down with Joe Ruffolo, SVP and General Manager at The Hill, to discuss how the healthcare distribution industry plays a vital role in mitigating the impact of drug shortages.
White Paper Shows PSAOs Provide Meaningful Support to the Vast Majority of Independent Pharmacies
Approximately 80 percent of independent retail and small chain pharmacies choose to use Pharmacy Services Administrative Organizations (PSAOs), as evidenced in a new white paper produced by Avalere Health.
A Dialogue on Healthcare Equity and the “Road Back from COVID-19”
On March 11, The 19th, an independent, nonprofit newsroom reporting on gender, politics and policy, hosted a virtual summit about healthcare equity in the context of the nation’s ongoing fight to defeat COVID-19. The event featured important and unique perspectives from the women directing the Biden-Harris administration’s pandemic response as well as other public health, health policy and healthcare industry leaders.
Healthcare Distributors Playing Central Role As COVID-19 Vaccination Campaign Accelerates
We have reached another pivotal moment in the fight against COVID-19: the Food and Drug Administration (FDA) has authorized Johnson & Johnson’s COVID-19 vaccine candidate for emergency use. With demand for vaccines currently outpacing supply, the addition of a third candidate is welcome news for Americans. Most importantly, a one-dose option that only requires refrigeration will provide greater flexibility in delivering vaccines to more individuals, including those in underserved and rural areas, with the ability to scale up production exponentially as we move into the spring and summer months.